Trials in UK, France and the Netherlands indicate tool can predict if patient will experience problems from surgery and radiotherapy
Doctors have developed an artificial intelligence tool that can predict which breast cancer patients are more at risk of side-effects after treatment.
Worldwide, 2 million women are diagnosed every year with the disease, which is the most common cancer in females in most countries.
